专题:Coagulation, Bradykinin, Polyphosphates, and Angioedema

This cluster of papers focuses on the molecular mechanisms, pathophysiological consequences, and clinical management of Hereditary Angioedema. It covers topics such as the role of kinin receptors, coagulation factors XII and XI, polyphosphate, C1 inhibitor deficiency, and the use of bradykinin-receptor antagonists in the treatment of angioedema. Additionally, it explores the involvement of tissue kallikreins and the contact activation system in the disease pathology.
最新文献
Treatment outcomes in patients with VEXAS syndrome: a retrospective cohort study

article Full Text OpenAlex

Cardiovascular disease risk in antineutrophil cytoplasmic antibody–associated vasculitis

letter Full Text OpenAlex

Becoming attack-free further improves health-related quality of life in patients with hereditary angioedema receiving garadacimab

article Full Text OpenAlex

Can depression and anxiety be predicted in hereditary angioedema? A comprehensive assessment

article Full Text OpenAlex

Angioedema without urticaria: Diagnosis and management

review Full Text OpenAlex

Garadacimab improves long-term health-related quality of life in patients with hereditary angioedema

article Full Text OpenAlex

Thrombospondin-1 inhibits alternative complement pathway activation in antineutrophil cytoplasmic antibody-associated vasculitis

article Full Text OpenAlex

Adherence and persistence among patients with hereditary angioedema receiving long-term prophylaxis in the United States

article Full Text OpenAlex

Analyzing social media conversations to gain insights into the experiences of patients with hereditary angioedema

article Full Text OpenAlex

Acquired Angioedema in a Patient on Everolimus Post-Heart Transplant

article Full Text OpenAlex

近5年高被引文献
Avacopan for the Treatment of ANCA-Associated Vasculitis

article Full Text OpenAlex 701 FWCI104.392

2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis

review Full Text OpenAlex 446 FWCI18.551

The international WAO/EAACI guideline for the management of hereditary angioedema—The 2021 revision and update

article Full Text OpenAlex 304 FWCI70.094

Pegcetacoplan versus Eculizumab in Paroxysmal Nocturnal Hemoglobinuria

article Full Text OpenAlex 287 FWCI24.821

Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study

article Full Text OpenAlex 241 FWCI56.8

Efficacy and safety of vutrisiran for patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy: a randomized clinical trial

article Full Text OpenAlex 232 FWCI23.955

Therapeutic options in VEXAS syndrome: insights from a retrospective series

review Full Text OpenAlex 228 FWCI10.436

Abelacimab for Prevention of Venous Thromboembolism

article Full Text OpenAlex 220 FWCI35.265

Milvexian for the Prevention of Venous Thromboembolism

article Full Text OpenAlex 194 FWCI30.901

Efficacy and Safety of Acoramidis in Transthyretin Amyloid Cardiomyopathy

article Full Text OpenAlex 176 FWCI81.021